Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Scc913
Boston, MA 02215Phone+1 617-667-9235
Education & Training
- University of WashingtonFellowship, Hematology and Medical Oncology, 1979 - 1982
- University of California (San Francisco)Residency, Internal Medicine, 1977 - 1979
- Detroit Medical Center/Wayne State University (Sinai Grace)Internship, Internal Medicine, 1976 - 1977
- University of California San Francisco School of MedicineClass of 1976
- University of CaliforniaMS, Medical Sciences, 1972 - 1974
- University of California, BerkeleyBA, Biochemistry, 1970 - 1972
Certifications & Licensure
- CA State Medical License 1977 - Present
- MA State Medical License 1983 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Start of enrollment: 2011 Sep 01
- A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- 8 citationsClinical characteristics and treatment outcomes among respiratory syncytial virus (RSV)-infected hematologic malignancy and hematopoietic stem cell transplant recipien...Nitipong Permpalung, Monica V Mahoney, Christopher McCoy, Amporn Atsawarungruangkit, Howard S. Gold
Leukemia & Lymphoma. 2019-01-02 - 202 citationsProspective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Pa...Robert J. Soiffer, Haesook T. Kim, Joseph P. McGuirk, Mitchell E. Horwitz, Laura Johnston
Journal of Clinical Oncology. 2017-10-17 - 128 citationsMUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemiaAthalia Rachel Pyzer, Dina Stroopinsky, Hasan Rajabi, Abigail Washington, Ashujit Tagde
Blood. 2017-03-30
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: